ArticleBritish journal of clinical pharmacology2021

No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study.

Roos S G Sablerolles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.